Citigroup’s T2 Biosystems, Inc TTOO Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q1 | – | Sell |
-237
| Closed | -$100 | – | 6113 |
|
|
2024
Q4 | $100 | Buy |
+237
| New | +$198 | ﹤0.01% | 5696 |
|
|
2022
Q2 | – | Sell |
-4
| Closed | -$10K | – | 6786 |
|
|
2022
Q1 | $10K | Buy |
+4
| New | +$8.49K | ﹤0.01% | 5560 |
|
|
2021
Q1 | – | Sell |
-2
| Closed | -$12K | – | 7628 |
|
|
2020
Q4 | $12K | Buy |
+2
| New | +$12.2K | ﹤0.01% | 6907 |
|
|
2020
Q1 | – | Sell |
-1
| Closed | -$4K | – | 7810 |
|
|
2019
Q4 | $4K | Hold |
1
| – | – | ﹤0.01% | 7470 |
|
|
2019
Q3 | $9K | Hold |
1
| – | – | ﹤0.01% | 7145 |
|
|
2019
Q2 | $8K | Sell |
1
-1
| -50% | -$11.7K | ﹤0.01% | 7373 |
|
|
2019
Q1 | $22K | Hold |
2
| – | – | ﹤0.01% | 6914 |
|
|
2018
Q4 | $25K | Hold |
2
| – | – | ﹤0.01% | 6767 |
|
|
2018
Q3 | $64K | Buy |
2
+1
| +100% | +$32.9K | ﹤0.01% | 6319 |
|
|
2018
Q2 | $30K | Buy |
+1
| New | +$38K | ﹤0.01% | 6694 |
|
|
2017
Q3 | – | Hold |
0
| – | – | – | 7497 |
|
|
2017
Q2 | – | Hold |
0
| – | – | – | 7521 |
|
|
2017
Q1 | – | Sell |
-1
| Closed | -$28.1K | – | 7120 |
|
|
2016
Q4 | $19K | Hold |
1
| – | – | ﹤0.01% | 6547 |
|
|
2016
Q3 | $26K | Buy |
+1
| New | +$32.8K | ﹤0.01% | 6080 |
|
|
2016
Q2 | – | Sell |
-2
| Closed | -$90.3K | – | 6940 |
|
|
2016
Q1 | $76K | Buy |
+2
| New | +$88.4K | ﹤0.01% | 5865 |
|
|
2015
Q4 | – | Hold |
0
| – | – | – | 7294 |
|
|
2015
Q3 | – | Hold |
0
| – | – | – | 7790 |
|
|
2015
Q2 | – | Hold |
0
| – | – | – | 7032 |
|
|
2015
Q1 | – | Sell |
-6
| Closed | -$557K | – | 6618 |
|
|
2014
Q4 | $553K | Buy |
+6
| New | +$495K | ﹤0.01% | 3779 |
|
|
2014
Q3 | – | Hold |
0
| – | – | – | 6033 |
|
Citigroup's TTOO Position: Q1 2025 in Review
Citigroup sold out of T2 Biosystems, Inc (TTOO) in Q1 2025, closing a stake of 237 shares — an estimated $100 sold.
Citigroup first reported a position in TTOO in Q4 2014 and held it in 14 quarters. The position peaked at $553K in Q4 2014. 2 funds tracked by Wall St. Rank hold TTOO as of Q1 2025.
- Citigroup reported no remaining T2 Biosystems, Inc position as of Q1 2025 after selling out during the quarter.
- Citigroup sold 237 T2 Biosystems, Inc shares in Q1 2025, an estimated $100.
- Citigroup first reported a position in T2 Biosystems, Inc in Q4 2014 and held it in 14 quarters.
- Citigroup's T2 Biosystems, Inc position peaked at $553K in Q4 2014.
- 2 funds tracked by Wall St. Rank held T2 Biosystems, Inc as of Q1 2025.
Based on Citigroup's 13F filing for Q1 2025, filed 12 May 2025.